• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CALM 干预对肺癌患者中性粒细胞与淋巴细胞比值(NLR)、癌症复发恐惧和生活质量的影响。

Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer.

机构信息

Department of Oncology, the Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.

Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, 518000, Guangdong, China.

出版信息

Support Care Cancer. 2023 Jul 7;31(7):447. doi: 10.1007/s00520-023-07929-7.

DOI:10.1007/s00520-023-07929-7
PMID:37414980
Abstract

PURPOSE

To evaluate the feasibility and practicability of Managing Cancer and Living Meaningfully (CALM) as a psychological intervention to reduce neutrophil to lymphocyte ratio (NLR), fear of cancer recurrence, general distress, and improve quality of life in lung cancer survivors.

METHODS

Eighty lung cancer patients with FCRI severity subscale (≥13 points) were recruited and randomly assigned to CALM or usual care (UC). NLR was recorded before and after treatment. The Fear of Cancer Recurrence Inventory (FCRI), Quality of Life Questionnaire Core 30 (QLQ-C30) and Depression-Anxiety-Stress Scale (DASS-21) were used to evaluate patients at baseline (T0), immediately after treatment (T1), and at 2 (T2) and 4 (T3) months.

RESULTS

Compared with UC, NLR was significantly different before and after CALM intervention (z=-5.498; P=0.000). There were significant differences in the scores of QLQ, FCR and general distress before and after the T1, T2 and T3 interventions (F=220.30, F=315.20, F=290.10, respectively; P<0.001). NLR was negatively correlated with QOL both before (r=-0.763; P<0.0001) and after the intervention (r=-0.810, P<0.0001). FCR and general distress were negatively correlated with QOL in CALM (T0: r=-0.726, r=-0.776, respectively; P<0.0001; T1: r=-0.664, r=-0.647, respectively; P<0.0001; T2: r=-0.678, r=-0.695, respectively; P<0.0001; T3: r=-0.511, P = 0.0008; r=-0.650, P<0.0001).

CONCLUSION

CALM intervention can effectively reduce the NLR, alleviate the recurrence fear and general distress and improve the quality of life in patients. This study suggests that CALM may be an effective psychological intervention for reducing symptoms associated with lung cancer survivors.

摘要

目的

评估管理癌症和有意义地生活(CALM)作为一种心理干预措施,以降低中性粒细胞与淋巴细胞比值(NLR)、癌症复发恐惧、一般困扰,并改善肺癌幸存者的生活质量的可行性和实用性。

方法

招募了 80 名 FCRI 严重程度亚量表(≥13 分)的肺癌患者,并随机分配至 CALM 或常规护理(UC)组。治疗前后记录 NLR。采用癌症复发恐惧量表(FCRI)、生活质量问卷核心 30 项(QLQ-C30)和抑郁焦虑压力量表(DASS-21)在基线(T0)、治疗后即刻(T1)以及 2(T2)和 4(T3)个月时评估患者。

结果

与 UC 相比,CALM 干预前后 NLR 差异有统计学意义(z=-5.498;P=0.000)。T1、T2 和 T3 干预前后 QLQ、FCR 和一般困扰评分差异均有统计学意义(F=220.30、F=315.20、F=290.10,P<0.001)。NLR 与干预前后的 QOL 均呈负相关(r=-0.763;P<0.0001;r=-0.810,P<0.0001)。CALM 中的 FCR 和一般困扰与 QOL 呈负相关(T0:r=-0.726、r=-0.776,P<0.0001;T1:r=-0.664、r=-0.647,P<0.0001;T2:r=-0.678、r=-0.695,P<0.0001;T3:r=-0.511,P=0.0008;r=-0.650,P<0.0001)。

结论

CALM 干预可有效降低 NLR,减轻复发恐惧和一般困扰,提高患者生活质量。本研究提示 CALM 可能是一种减轻肺癌幸存者相关症状的有效心理干预措施。

相似文献

1
Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer.CALM 干预对肺癌患者中性粒细胞与淋巴细胞比值(NLR)、癌症复发恐惧和生活质量的影响。
Support Care Cancer. 2023 Jul 7;31(7):447. doi: 10.1007/s00520-023-07929-7.
2
Positive influence of managing cancer and living meaningfully (CALM) on fear of cancer recurrence in breast cancer survivors.管理癌症与有意义生活(CALM)对乳腺癌幸存者癌症复发恐惧的积极影响
Am J Cancer Res. 2023 Jul 15;13(7):3067-3079. eCollection 2023.
3
Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.随机对照试验 ConquerFear:一种基于理论的新型癌症恐惧复发的心理社会干预方法。
J Clin Oncol. 2017 Dec 20;35(36):4066-4077. doi: 10.1200/JCO.2017.73.1257. Epub 2017 Nov 2.
4
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.接受与承诺疗法治疗乳腺癌恐惧复发患者的 3 臂先导随机对照试验。
Cancer. 2020 Jan 1;126(1):211-218. doi: 10.1002/cncr.32518. Epub 2019 Sep 20.
5
Managing cancer and living meaningfully (CALM) as an intervention for severe fatigue in gastrointestinal cancer survivors.管理癌症并活得有意义(CALM)作为胃肠道癌症幸存者严重疲劳的一种干预措施。
Am J Cancer Res. 2022 Jun 15;12(6):2721-2732. eCollection 2022.
6
Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors.《ConquerFear-HK 研究方案:一项基于元认知、针对癌症康复者恐惧癌症复发的手册化干预的随机对照试验》。
BMJ Open. 2023 Jan 20;13(1):e065075. doi: 10.1136/bmjopen-2022-065075.
7
Feasibility of online managing cancer and living meaningfully (CALM) in Chinese patients with metastatic breast cancer: a pilot randomized control trial.在线管理癌症和赋予意义(CALM)对中国转移性乳腺癌患者的可行性:一项试点随机对照试验。
Sci Rep. 2024 Feb 28;14(1):4892. doi: 10.1038/s41598-024-52574-7.
8
Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.探讨一项针对女性癌症幸存者癌症复发恐惧的干预措施初步疗效的随机对照临床试验初步研究。
Support Care Cancer. 2018 Aug;26(8):2751-2762. doi: 10.1007/s00520-018-4097-1. Epub 2018 Mar 2.
9
A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan.台湾妇科癌症幸存者的癌症复发恐惧、疾病表征、自我调节与生活质量的相关性研究
Taiwan J Obstet Gynecol. 2018 Dec;57(6):846-852. doi: 10.1016/j.tjog.2018.10.014.
10
Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.一项针对乳腺癌或妇科癌症女性的复发恐惧疗法(FORT)干预随机对照试验方案。
BMC Cancer. 2016 Apr 25;16:291. doi: 10.1186/s12885-016-2326-x.

引用本文的文献

1
Effectiveness of Managing Cancer and Living Meaningfully Therapy on Health-Related Outcomes for Patients With Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.癌症管理与有意义生活疗法对癌症患者健康相关结局的有效性:随机对照试验的系统评价与荟萃分析
Worldviews Evid Based Nurs. 2025 Apr;22(2):e70023. doi: 10.1111/wvn.70023.
2
Effects of the CALM intervention on cancer-related fatigue and heart rate variability in NSCLC: a randomized trial.CALM干预对非小细胞肺癌患者癌症相关疲劳和心率变异性的影响:一项随机试验。
Future Oncol. 2024 Dec;20(39):3289-3300. doi: 10.1080/14796694.2024.2428586. Epub 2024 Nov 15.
3

本文引用的文献

1
Social support can alleviate the fear of cancer recurrence in postoperative patients with lung carcinoma.社会支持可以减轻肺癌术后患者对癌症复发的恐惧。
Am J Transl Res. 2022 Jul 15;14(7):4804-4811. eCollection 2022.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors.乳腺癌幸存者对癌症复发的恐惧及其对健康相关生活质量的负面影响。
Systemic and local immunosuppression in glioblastoma and its prognostic significance.
脑胶质瘤的全身和局部免疫抑制及其预后意义。
Front Immunol. 2024 Feb 28;15:1326753. doi: 10.3389/fimmu.2024.1326753. eCollection 2024.
Cancer Res Treat. 2022 Oct;54(4):1065-1073. doi: 10.4143/crt.2021.835. Epub 2021 Dec 8.
4
Facilitators and barriers perceived by health professionals in the implementation of Managing Cancer and Living Meaningfully (CALM) psychotherapy in Santiago.圣地亚哥的医疗专业人员在实施“管理癌症与有意义地生活”(CALM)心理治疗过程中所察觉到的促进因素和障碍。
Ecancermedicalscience. 2021 Jun 30;15:1256. doi: 10.3332/ecancer.2021.1256. eCollection 2021.
5
Associations between the spiritual well-being (EORTC QLQ-SWB32) and quality of life (EORTC QLQ-C30) of patients receiving palliative care for cancer in Cyprus.塞浦路斯癌症姑息治疗患者的精神幸福感(EORTC QLQ-SWB32)与生活质量(EORTC QLQ-C30)之间的关联。
BMC Palliat Care. 2021 Aug 30;20(1):133. doi: 10.1186/s12904-021-00830-2.
6
Quality of Life and Psychological Distress of Lung Cancer Patients Undergoing Chemotherapy.接受化疗的肺癌患者的生活质量和心理困扰
World J Oncol. 2021 Jun;12(2-3):61-66. doi: 10.14740/wjon1371. Epub 2021 May 14.
7
Impact of neutrophil-to-lymphocyte ratio throughout the course of chemoradiotherapy on overall survival and distant failure in unresectable stage III non-small cell lung cancer.中性粒细胞与淋巴细胞比值在不可切除 III 期非小细胞肺癌放化疗过程中对总生存期和远处失败的影响。
Jpn J Radiol. 2021 Sep;39(9):914-922. doi: 10.1007/s11604-021-01129-1. Epub 2021 May 17.
8
Factor structure of the Fear of Cancer Recurrence Inventory (FCRI): Comparison of international FCRI factor structure data and factor analysis of the Dutch FCRI-NL using three predominantly breast cancer samples.恐惧癌症复发量表(FCRI)的因子结构:国际 FCRI 因子结构数据的比较,以及使用三个主要为乳腺癌样本的荷兰 FCRI-NL 的因子分析。
Eur J Cancer Care (Engl). 2021 Sep;30(5):e13431. doi: 10.1111/ecc.13431. Epub 2021 Mar 25.
9
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors.预处理中性粒细胞与淋巴细胞比值和突变负担作为免疫检查点抑制剂肿瘤反应的生物标志物。
Nat Commun. 2021 Feb 1;12(1):729. doi: 10.1038/s41467-021-20935-9.
10
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies.中性粒细胞与淋巴细胞比值与癌症预后:观察性研究系统评价和荟萃分析的伞状评价。
BMC Med. 2020 Nov 20;18(1):360. doi: 10.1186/s12916-020-01817-1.